Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China

BACKGROUND: CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL) is a rare subtype of DLBCL with invasive clinical features and poor prognosis. Current clinical variables based on prognostic systems for DLBCL are inadequate to accurately stratify the prognosis of CD5+ DLBCL. METHODS: A total of 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ziyuan, Wang, Ling, Zhang, Bingpei, Li, Tianci, Li, Dashan, He, Chenlu, Xue, Yuhao, Wang, Ying, Li, Bingzong, Liu, Qinhua, Zhang, Hao, Gu, Weiying, Wang, Fei, Wang, Chunling, Shi, Yuye, Ye, Jingjing, Zhu, Taigang, Miao, Yuqing, Huang, Shuiping, Sang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595286/
https://www.ncbi.nlm.nih.gov/pubmed/34804942
http://dx.doi.org/10.3389/fonc.2021.754180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595286/
https://www.ncbi.nlm.nih.gov/pubmed/34804942
http://dx.doi.org/10.3389/fonc.2021.754180

Ejemplares similares